Regulatory T cells in human disease and their potential for therapeutic manipulation

  • Taams L
  • Palmer D
  • Akbar A
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Regulatory T cells are proposed to play a central role in the maintenance of immunological tolerance in the periphery, and studies in many animal models demonstrate their capacity to inhibit inflammatory pathologies in vivo. At a recent meeting [Clinical Application of Regulatory T Cells, 7-8 April 2005, Horsham, UK, organized by the authors of this review, in collaboration with the British Society for Immunology and Novartis] evidence was discussed that certain human autoimmune, infectious and allergic diseases are associated with impaired regulatory T-cell function. In contrast, evidence from several human cancer studies and some infections indicates that regulatory T cells may impair the development of protective immunity. Importantly, certain therapies, both those that act non-specifically to reduce inflammation and antigen-specific immunotherapies, may induce or enhance regulatory T-cell function. The purpose of this review was to summarize current knowledge on regulatory T-cell function in human disease, and to assess critically how this can be tailored to suit the therapeutic manipulation of immunity

Author-supplied keywords

  • Autoimmunity
  • Humans
  • Immune System Diseases
  • Immune Tolerance
  • Immunity
  • Immunotherapy
  • Infection
  • Inflammation
  • Neoplasms
  • T-Lymphocytes,Regulatory
  • immunology
  • methods
  • pathology
  • therapy

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

  • PMID: 16630018


  • L S Taams

  • D B Palmer

  • A N Akbar

  • D S Robinson

  • Z Brown

  • C M Hawrylowicz

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free